On April 15, the FDA published a notice scheduling a meeting of the Pharmacy Compounding Advisory Committee (PCAC) for July 2324, 2026, at which the committee will consider whether to recommend certain peptide bulk drug substances for inclusion on the 503A bulks list
Studies in animal models have indicated that BPC-157 research compounds may promote angiogenesis, the formation of new blood vessels, through VEGF-mediated pathways (Chang et al., 2011)
Useful Avion BioLabs resources
Each agency has cycles where solicitations open at specific times of the year and/or a specific number of times a year
When combined, these two compounds address cellular health from complementary angles, creating a protocol that supports both systemic vitality and targeted tissue repair
If youre thinking about buying BPC-157, its key to know how to use it right